Abivax SA American Depositary Shares (ABVX NASDAQ) stock market data APIs
$80.3002
2.37(3%)
as of September 17, 2025
Try our APIs with
free plan!
Abivax SA American Depositary Shares Financial Data Overview
Price chart is built with
Anychart
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Prev. Close
80.3002
Open
82.6657
High
84.8545
Low
79.925
52 wk Range
4.77-92.91
Market Cap
6 272 M
Shares Outstanding
77 434 K
Revenue
6 023 K
EPS
-0.89
Beta
0.127
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Abivax SA American Depositary Shares data using free add-ons & libraries
Get Abivax SA American Depositary Shares Fundamental Data
Abivax SA American Depositary Shares Fundamental data includes:
- Net Revenue: 6 023 K
- EBITDA: -185 652 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-09-08
- EPS/Forecast: -0.95
Get Abivax SA American Depositary Shares End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Abivax SA American Depositary Shares News
New
SA Asks: Which biotechs could be acquired by year's end?
[word m and a made with wood building blocks, stock image] Maksim Labkouski The fourth quarter has historically been a busy time for the biopharma industry, with the sector generally seeing a signifi...
Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review
Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review PARIS, France, September 12, 2025, 5:45 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq �...
Abivax Presents First Half 2025 Financial Results
Abivax Presents First Half 2025 Financial Results PARIS, France, September 8, 2025, 10:00 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the “Com...
Abivax jumps amid takeover speculation
[Torn pieces of paper with the words Ulcerative Colitis] Professor25/iStock via Getty Images Abivax (NASDAQ:ABVX [https://seekingalpha.com/symbol/ABVX]) shares rose 6.9% in Paris amid takeover specul...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
